News

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Opdivo  (nivolumab) for the treatment of adult patients with resectable (tumors ≥4 cm or node…
Read More...

Recordati announces an agreement with Sanofi to acquire the global rights to Enjaymo (sutimlimab), a biologic which is the only approved targeted product for the treatment of cold…
Read More...

Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the treatment of…
Read More...

Charles River Laboratories International, Inc. announced an agreement with H. Lundbeck A/S (Lundbeck) to utilize Logica to progress critical brain disease research. “We are excited…
Read More...

Arcus Biosciences, Inc. announced a clinical trial collaboration agreement with AstraZeneca to evaluate casdatifan (AB521), Arcus’s investigational HIF-2a inhibitor, in combination with…
Read More...

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced the successful completion of its acquisition of a…
Read More...

ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that it has entered into a clinical trial collaboration and supply agreement with MSD (a…
Read More...

Gilead Sciences, Inc. announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six pharmaceutical manufacturers to make and sell generic lenacapavir,…
Read More...

ImmunoPrecise Antibodies Ltd., an AI-driven biotherapeutic research and technology company, and Biotheus Inc. (Biotheus), a clinical-stage biotech company dedicated to the discovery and…
Read More...

GenEditBio Limited, a biotech company co-founded by Prof. ZHENG Zongli from the City University of Hong Kong that focuses on precision genome editing to provide affordable "precision…
Read More...

To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutical companies, Thermo Fisher Scientific Inc. is expanding its oral…
Read More...

Acumen Pharmaceuticals, a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta (Aβ) oligomers (AβOs) for the treatment of…
Read More...

Bayer announced the inauguration of its new life science incubator, Bayer Co.Lab Shanghai, in the Shanghai Innovation (SH-INNO) Park at the heart of China´s largest biopharma cluster,…
Read More...

Boehringer Ingelheim has entered a partnership with the NCD Alliance, a network dedicated to shaping a world in which everyone can live a healthy and productive life, free from the…
Read More...

Phare Bio, along with the Collins Lab at the Massachusetts Institute of Technology (MIT) and Harvard's Wyss Institute, announced that they have been awarded up to $27 million in funding…
Read More...

Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, today announces an expansion to its collaboration with Takeda that takes…
Read More...

AstraZeneca’s Tagrisso (osimertinib)​ has been approved in the US for the treatment of adult patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm)…
Read More...

Pfizer Inc. announced that it is voluntarily withdrawing all lots of OXBRYTA (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where it is…
Read More...

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announced a new strategic…
Read More...

The Ministry of Health, Labour and Welfare Japan has approved Kisunla (donanemab-azbt, 350 mg/20 mL every four weeks injection for IV infusion), Eli Lilly and Company's Alzheimer's…
Read More...